Literature DB >> 9224230

Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis.

H Bachelez1, B Schremmer, J Cadranel, F Mouly, C Sarfati, F Agbalika, B Schlemmer, C M Mayaud, L Dubertret.   

Abstract

Between 1989 and 1996, 4 cases of Pneumocystis carinii pneumonia (PCP) were observed in patients seronegative for the human immunodeficiency virus who were receiving corticosteroid therapy for dermatomyositis in our institution. These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course: 3 of these patients died of PCP occurring during the first month of treatment with prednisone. In all 4 patients lymphopenia was observed before the initiation of corticosteroid treatment and low CD4 and CD8 cell counts were evident at the time of PCP. These observations support the view of an increase in both the severity and incidence of PCP in patients without human immunodeficiency virus infection and question the need for a primary prophylaxis in patients with connective tissue diseases receiving high-dose corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224230

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

Review 1.  Drug-induced lymphopenia: focus on CD4+ and CD8+ cells.

Authors:  P Gergely
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

2.  Red fist and muscle weakness with a rare complication.

Authors:  Iris van Groeningen; Joyce Arnoldus; Roos Perenboom; Alexandre Voskuyl
Journal:  BMJ Case Rep       Date:  2014-02-20

Review 3.  Pulmonary complications of inflammatory myopathy.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

4.  Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.

Authors:  Jing Wang; Francis Gigliotti; Samir P Bhagwat; Thaddeus C George; Terry W Wright
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

Review 5.  The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review.

Authors:  Alan K L Wu; Vincent C C Cheng; Bone S F Tang; Ivan F N Hung; Rodney A Lee; David S Hui; Kwok Y Yuen
Journal:  BMC Infect Dis       Date:  2004-12-09       Impact factor: 3.090

6.  A multi-centered study of Pneumocystis jirovecii colonization in patients with respiratory disorders: Is there a colonization trend in the elderly?

Authors:  Mahdi Abastabar; Elham Mosayebi; Tahereh Shokohi; Mohammad T Hedayati; Mohammad R Jabari Amiri; Zahra Seifi; Iman Haghani; Masoud Aliyali; Sassan Saber; Maryam-Fatemeh Sheikholeslami
Journal:  Curr Med Mycol       Date:  2019-09

Review 7.  Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention.

Authors:  Evin Sowden; Andrew J Carmichael
Journal:  BMC Infect Dis       Date:  2004-10-16       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.